ArticleJACC. Advances2026

Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases.

Chuyue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.